File: b-be-03-b3-fiche-dinformation-destinee-au-public.pdfTrial reference: Phase I multicentre study of TG1024 (Adenovirus interleukin 2) in patients with metastatic melanoma or other advanced solid tumor cancersDoc type: Information for the public
